Skip to main content
. 2017 Jun 29;2017(6):CD011412. doi: 10.1002/14651858.CD011412.pub2
Methods Randomised, open‐label, parallel‐group trial conducted in Republic of Korea
2 treatment arms: OXC and TPM
Participants Children with newly diagnosed epilepsy
Number randomised: OXC = 20, TPM = 25
Interventions Monotherapy OXC or TPM
Doses started and achieved not stated
Trial duration: 16 weeks
Outcomes Seizure freedom
Seizure frequency
Adverse events
Notes Full text of the trial available only in Korean (English abstract). Awaiting translation of the full text